ARSMO Plastic Aesthetic Hospital Holding Co., Ltd. has announced the inaugural application of GOURI, a fully liquid polycaprolactone (PCL) based dermal filler, in its Hainan-based unit. GOURI is a renewable material that utilizes CESABP technology, allowing it to be fully liquid and to decompose gradually, thereby promoting the natural regeneration of skin collagen without relying on particle use. Since receiving marketing approval from the European Union in 2021, GOURI has been adopted in nearly 60 countries and regions worldwide.- Flcube.com
Recent news:
-
Sino Biopharmaceutical Submits NDA for Anlotinib and Penpulimab Combo in HCC to NMPA -
Sihuan Pharmaceutical's Huisheng Pharm Strikes Exclusive Deal for Semaglutide Biosimilar in China -
Innovent Biologics' IBI354 Earns Breakthrough Therapy Designation for Ovarian Cancer Treatment -
CDE Includes Double-Crane's Hydroxocobalamine and Sanofi Genzyme's Fitusiran in Rare Disease Care Plan -
Apeiron Therapeutics Initiates Phase Ia/B Study for GTA182 in Solid Tumors with MTAP Deficiency
